3 Patents
- US125645912026HCK as a Therapeutic Target in MYD88 Mutated Diseases
Dana-farber Cancer Institute, Inc.
0 cites - 0 cites
- US117393852023Discovery of a Somatic Mutation in MYD88 Gene in Lymphoplasmacytic Lymphoma
Dana-farber Cancer Institute, Inc.
0 cites